281 related articles for article (PubMed ID: 24573171)
1. Effects of topical sphingosine-1-phosphate 1 receptor agonist on corneal allograft in mice.
Jia L; Liu Y; Wang L; Zhu J; Huang Y
Cornea; 2014 Apr; 33(4):398-404. PubMed ID: 24573171
[TBL] [Abstract][Full Text] [Related]
2. Systemic application of sphingosine 1-phosphate receptor 1 immunomodulator inhibits corneal allograft rejection in mice.
Zhu J; Liu Y; Pi Y; Jia L; Wang L; Huang Y
Acta Ophthalmol; 2014 Feb; 92(1):e12-21. PubMed ID: 23910624
[TBL] [Abstract][Full Text] [Related]
3. Topical application of sphingosine 1-phosphate receptor 1 prolongs corneal graft survival in mice.
Zhu J; Liu Y; Huang Y
Mol Med Rep; 2015 May; 11(5):3800-7. PubMed ID: 25607596
[TBL] [Abstract][Full Text] [Related]
4. Topical application of FTY720 and cyclosporin A prolong corneal graft survival in mice.
Liu Y; Jiang J; Xiao H; Wang X; Li Y; Gong Y; Wang D; Huang Y
Mol Vis; 2012; 18():624-33. PubMed ID: 22509094
[TBL] [Abstract][Full Text] [Related]
5. Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.
Lan YY; Tokita D; Wang Z; Wang HC; Zhan J; Brinkmann V; Thomson AW
Transpl Immunol; 2008 Nov; 20(1-2):88-94. PubMed ID: 18694829
[TBL] [Abstract][Full Text] [Related]
6. Prolonging survival of corneal transplantation by selective sphingosine-1-phosphate receptor 1 agonist.
Gao M; Liu Y; Xiao Y; Han G; Jia L; Wang L; Lei T; Huang Y
PLoS One; 2014; 9(9):e105693. PubMed ID: 25216235
[TBL] [Abstract][Full Text] [Related]
7. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. II. FTY720 prolongs skin allograft survival by decreasing T cell infiltration into grafts but not cytokine production in vivo.
Yanagawa Y; Sugahara K; Kataoka H; Kawaguchi T; Masubuchi Y; Chiba K
J Immunol; 1998 Jun; 160(11):5493-9. PubMed ID: 9605152
[TBL] [Abstract][Full Text] [Related]
8. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
9. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
[TBL] [Abstract][Full Text] [Related]
10. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
[TBL] [Abstract][Full Text] [Related]
11. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
[TBL] [Abstract][Full Text] [Related]
12. [Immunosuppressive effect of S1P1 receptor agonist FTY720].
Zhou WQ; Zhang HJ; Jin J; Li Y; Li C; Chen XG
Yao Xue Xue Bao; 2012 Apr; 47(4):546-50. PubMed ID: 22799042
[TBL] [Abstract][Full Text] [Related]
13. Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation.
Song J; Hagiya H; Kurata H; Mizuno H; Ito T
Transpl Immunol; 2012 Mar; 26(2-3):163-70. PubMed ID: 22210496
[TBL] [Abstract][Full Text] [Related]
14. Specific immunosuppression of corneal allograft rejection by combination of anti-VLA-4 and anti-LFA-1 monoclonal antibodies in mice.
Hori J; Isobe M; Yamagami S; Mizuochi T; Tsuru T
Exp Eye Res; 1997 Jul; 65(1):89-98. PubMed ID: 9237869
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
16. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
[TBL] [Abstract][Full Text] [Related]
17. Adoptive transfer of donor corneal antigen-specific regulatory T cells can prolong mice corneal grafts survival.
He Y; Jie Y; Wang B; Zeng H; Zhang Y; Pan Z
Cornea; 2010 Nov; 29 Suppl 1():S25-31. PubMed ID: 20935538
[TBL] [Abstract][Full Text] [Related]
18. FTY720 in combination with cyclosporine--an analysis of skin allograft survival and renal function.
Silva FR; Silva LB; Cury PM; Burdmann EA; Bueno V
Int Immunopharmacol; 2006 Dec; 6(13-14):1911-8. PubMed ID: 17161344
[TBL] [Abstract][Full Text] [Related]
19. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
20. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
Shi W; Chen M; Xie L
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
